A New Species of Scorpio from Saudi Arabia (Scorpiones: Scorpionidae)

Posted by
  A New Species of Scorpio from Saudi Arabia (Scorpiones: Scorpionidae)  Abstract A new species of  Scorpio  Linnaeus, 1758 is described from Al Ula Governorate, Al Madinah Province, Saudi Arabia.  Scorpio furvus  sp. nov. is distinguished from closely related congeners, including  S. fuscus ,  S. kruglovi ,  S. palmatus ,  S. jordanensis , and  S. yemenensis , by a unique combination of morphological characters notably the granulation pattern of the pedipalp chela, metasomal proportions, pectinal structure and length, and overall dark coloration. Morphometric comparisons further support its distinct status. The discovery of this species highlights the underestimated diversity of the genus  Scorpio  in the Arabian Peninsula and reinforces the view that the  Scorpio maurus  complex comprises multiple geographically restricted taxa requiring continued integrative taxonomic investigation. Aloufi, A., Afifeh, B. A., ...

Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine

Posted by

 

By Leandro Avelar - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=49733700

Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine

Abstract

Cancer remains a significant global health challenge, prompting the search for novel therapeutic strategies that minimize the limitations of current treatments. Crotamine, a cationic myotoxin isolated from the venom of Crotalus durissus spp., has emerged as a promising anticancer candidate due to its selective cytotoxicity toward tumor cells and multifaceted biological activities. This review examines the structural and functional characteristics of crotamine, emphasizing its mechanisms of action, such as disruption of ionic homeostasis through calcium influx, inhibition of voltage-gated potassium channels (Kv), and its preferential uptake by proliferating cells as a cell-penetrating peptide (CPP). Moreover, crotamine facilitates the intracellular delivery of bioactive compounds, enhancing drug selectivity and efficacy. Preclinical studies have demonstrated its ability to inhibit tumor growth both in vitro and in vivo, with minimal toxicity to normal tissues and low immunogenicity. These features position crotamine as a strong candidate for anticancer drug development. However, further investigation is essential to fully elucidate its molecular targets and mechanisms and to support its clinical translation.
Jacob, B., Alberghini-dos-Santos, J., Ferreira, I., Vieira, B., Malachias-Pires, G., Cerni, F., Pucca, M., Arantes, E., & Oliveira, I. (2025). Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine. Toxicon, 108670. https://doi.org/10.1016/j.toxicon.2025.108670